Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
1,051.99
+29.97 (2.93%)
At close: Feb 27, 2026, 4:00 PM EST
1,049.00
-2.99 (-0.28%)
After-hours: Feb 27, 2026, 7:59 PM EST
Eli Lilly Employees
Eli Lilly and Company had 50,000 employees as of December 31, 2025. The number of employees increased by 3,000 or 6.38% compared to the previous year.
Employees
50,000
Change (1Y)
3,000
Growth (1Y)
6.38%
Revenue / Employee
$1,303,580
Profits / Employee
$412,800
Market Cap
939.80B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 50,000 | 3,000 | 6.38% |
| Dec 31, 2024 | 47,000 | 4,000 | 9.30% |
| Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
| Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
| Dec 31, 2021 | 35,000 | 0 | - |
| Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
| Dec 31, 2019 | 33,625 | -5,055 | -13.07% |
| Dec 31, 2018 | 38,680 | -1,975 | -4.86% |
| Dec 31, 2017 | 40,655 | -1,320 | -3.14% |
| Dec 31, 2016 | 41,975 | 700 | 1.70% |
| Dec 31, 2015 | 41,275 | 2,140 | 5.47% |
| Dec 31, 2014 | 39,135 | 1,210 | 3.19% |
| Dec 31, 2013 | 37,925 | -425 | -1.11% |
| Dec 31, 2012 | 38,350 | 270 | 0.71% |
| Dec 31, 2011 | 38,080 | -270 | -0.70% |
| Dec 31, 2010 | 38,350 | -2,010 | -4.98% |
| Dec 31, 2009 | 40,360 | -140 | -0.35% |
| Dec 31, 2008 | 40,500 | -100 | -0.25% |
| Dec 31, 2007 | 40,600 | -900 | -2.17% |
| Dec 31, 2006 | 41,500 | -1,100 | -2.58% |
| Dec 31, 2005 | 42,600 | -1,900 | -4.27% |
| Dec 31, 2004 | 44,500 | -1,600 | -3.47% |
| Dec 31, 2003 | 46,100 | 2,400 | 5.49% |
| Dec 31, 2002 | 43,700 | 2,600 | 6.33% |
| Dec 31, 2001 | 41,100 | 5,400 | 15.13% |
| Dec 31, 2000 | 35,700 | 4,400 | 14.06% |
| Dec 31, 1999 | 31,300 | 1,500 | 5.03% |
| Dec 31, 1998 | 29,800 | -1,300 | -4.18% |
| Dec 31, 1997 | 31,100 | 1,900 | 6.51% |
| Dec 31, 1996 | 29,200 | 2,400 | 8.96% |
| Dec 31, 1995 | 26,800 | 1,900 | 7.63% |
| Dec 31, 1994 | 24,900 | -7,800 | -23.85% |
| Dec 31, 1993 | 32,700 | 500 | 1.55% |
| Dec 31, 1992 | 32,200 | 1,400 | 4.55% |
| Dec 31, 1991 | 30,800 | 1,300 | 4.41% |
| Dec 31, 1990 | 29,500 | 1,700 | 6.12% |
| Dec 31, 1989 | 27,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| AstraZeneca | 95,100 |
| Novartis AG | 75,267 |
| Merck & Co. | 75,000 |
| Pfizer | 75,000 |
| Novo Nordisk | 69,505 |
| GSK plc | 68,629 |
| AbbVie | 57,000 |
LLY News
- 1 day ago - Lilly's Olumiant (baricitinib) recommended by CHMP for approval of expanded use in the European Union for adolescents with severe alopecia areata - PRNewsWire
- 2 days ago - Eli Lilly reports additional data on weight-loss pill from diabetes trial - Reuters
- 2 days ago - Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet - PRNewsWire
- 3 days ago - Columbia Balanced Fund Q4 2025 Contributors And Detractors - Seeking Alpha
- 4 days ago - Novo Nordisk and Eli Lilly shares both fall after Ozempic price-cut plan - Market Watch
- 4 days ago - Novo's stumbles burnish Lilly's widening lead in weight-loss drugs - Reuters
- 5 days ago - Eli Lilly's Zepbound Gets FDA OK for Multi-Dose Pen - WSJ
- 5 days ago - Novo Nordisk's Loss Is Eli Lilly's Gain - Benzinga